Related Experiment Video
Updated: Apr 20, 2026
04:20
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
6.4K
Defining the system: contributors to exercise limitations in heart failure
Shane A Phillips1, Karen Vuckovic2, Lawrence P Cahalin3
1Department of Physical Therapy, College of Applied Health Sciences, University of Illinois at Chicago, 1919 West Taylor Street, MC 898, Chicago, IL 60612, USA; Integrative Physiology Laboratory, College of Applied Health Sciences, University of Illinois at Chicago, 1919 West Taylor Street, Chicago, IL 60612, USA.
Heart Failure Clinics
|November 30, 2014
Summary
Heart failure (HF) reduces exercise tolerance due to impaired heart function and changes in blood vessels, muscles, and lungs. Understanding these mechanisms is key to developing new therapies for heart failure patients.
Area of Science:
- Cardiology
- Exercise Physiology
- Pathophysiology
Background:
- Heart failure (HF) is characterized by reduced exercise tolerance and functional capacity.
- This limitation arises from cardiac dysfunction and peripheral alterations in vasculature, skeletal muscle, and respiratory systems.
- The complex interplay between central and peripheral factors contributes significantly to exercise intolerance in HF.
Purpose of the Study:
- To review the current literature on the pathophysiology of exercise intolerance in heart failure.
- To explore the central and peripheral mechanisms underlying reduced functional capacity in HF patients.
- To provide insights for the development of future therapeutic strategies to improve outcomes.
Main Methods:
- Comprehensive literature review of studies investigating exercise intolerance in heart failure.
- Analysis of central (cardiac) and peripheral (vasculature, skeletal muscle, respiratory) mechanisms.
- Synthesis of current understanding regarding the pathophysiology of HF-related exercise limitation.
Main Results:
- Reduced cardiac output and impaired chronotropic response are key central factors.
- Peripheral adaptations include skeletal muscle abnormalities, endothelial dysfunction, and altered respiratory mechanics.
- The interconnectedness of these systems exacerbates exercise intolerance.
Conclusions:
- Understanding the multifaceted pathophysiology of exercise intolerance in HF is crucial.
- Targeting both central and peripheral mechanisms may offer novel therapeutic avenues.
- Further research into system interrelationships can guide the design of effective interventions for HF.
Related Concept Videos
01:26Imbalances in Cardiac Output
3.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
01:20Exercise and Cardiovascular Response
6.5K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.5K
01:27Heart Failure I: Introduction
1.4K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:30Heart Failure VII: Nursing Interventions
771
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
771
01:22Heart Failure VI: Adjunct Therapies
614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614